We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRA
5026
DELISTED
Comera Life Sciences Holdings, Inc. Common Stock
CMRA
$5K ﹤0.01%
5,566
+4,272
+330% +$5.37K
SBIG
5027
DELISTED
SpringBig Holdings, Inc. Common Stock
SBIG
$5K ﹤0.01%
+7,419
New +$5.67K
PNAC
5028
DELISTED
Prime Number Acquisition I Corp. Class A Common Stock
PNAC
$5K ﹤0.01%
487
+112
+30% +$1.15K
SUNL
5029
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$5K ﹤0.01%
753
-124
-14% -$2.73K
WTT
5030
DELISTED
Wireless Telecom Group, Inc.
WTT
$5K ﹤0.01%
2,754
+641
+30% +$1.2K
IMBI
5031
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$5K ﹤0.01%
8,990
-1,720
-16% -$1.19K
DNAB
5032
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$5K ﹤0.01%
469
+290
+162% +$2.94K
BSDE
5033
DELISTED
Invesco BulletShares 2024 USD Emerging Markets Debt ETF
BSDE
$5K ﹤0.01%
+222
New +$5.34K
PTE
5034
DELISTED
PolarityTE, Inc. Common Stock
PTE
$5K ﹤0.01%
9,756
+3
+0% +$2
BSCN
5035
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$5K ﹤0.01%
232
+32
+16% +$673
MTRYU
5036
DELISTED
Monterey Innovation Acquisition Corp. Unit
MTRYU
$5K ﹤0.01%
445
AMTX icon
5037
Aemetis
AMTX
$128M
$4K ﹤0.01%
1,786
+1,576
+750% +$5.87K
APLM icon
5038
Apollomics
APLM
$51.4M
$4K ﹤0.01%
+2
New +$5.36K
ASNS
5039
DELISTED
ACTELIS NETWORKS INC
ASNS
$4K ﹤0.01%
137
+41
+43% +$2.02K
ASST icon
5040
Strive Inc
ASST
$1.05B
$4K ﹤0.01%
+27
New +$4.91K
FRMM
5041
Forum Markets
FRMM
$80.4M
$4K ﹤0.01%
12
-16
-57% -$9.3K
AVTX icon
5042
Avalo Therapeutics
AVTX
$1.05B
$4K ﹤0.01%
+10
New +$7.88K
AWRE icon
5043
Aware
AWRE
$26.4M
$4K ﹤0.01%
+2,787
New +$4.78K
AYTU icon
5044
AYTU BioPharma
AYTU
$25.5M
$4K ﹤0.01%
1,726
+113
+7% +$331
BARK icon
5045
BARK
BARK
$91.4M
$4K ﹤0.01%
146
-337
-70% -$10.7K
BCDA icon
5046
BioCardia
BCDA
$14.5M
$4K ﹤0.01%
140
+67
+92% +$2.22K
BJDX icon
5047
Bluejay Diagnostics
BJDX
$1.09M
0
BLZE icon
5048
Backblaze
BLZE
$1.18B
$4K ﹤0.01%
690
-1,614
-70% -$9.78K
BRTX icon
5049
BioRestorative Therapies
BRTX
$5.76M
$4K ﹤0.01%
1,212
-2,969
-71% -$9.11K
SRXH
5050
SRX Global
SRXH
$37.5M
$4K ﹤0.01%
6

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.